MX2020005584A - Vacunacion con particulas de replicon y adyuvante oleoso. - Google Patents

Vacunacion con particulas de replicon y adyuvante oleoso.

Info

Publication number
MX2020005584A
MX2020005584A MX2020005584A MX2020005584A MX2020005584A MX 2020005584 A MX2020005584 A MX 2020005584A MX 2020005584 A MX2020005584 A MX 2020005584A MX 2020005584 A MX2020005584 A MX 2020005584A MX 2020005584 A MX2020005584 A MX 2020005584A
Authority
MX
Mexico
Prior art keywords
vaccination
oil adjuvant
replicon particles
particles
replicon
Prior art date
Application number
MX2020005584A
Other languages
English (en)
Inventor
Mogler Mark A
Erin Strait
Ruud Philip Antoon Maria Segers
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2020005584A publication Critical patent/MX2020005584A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/193—Equine encephalomyelitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a la vacunación contra patógenos de animales a través del uso de partículas de ARN de replicón de alfavirus y adyuvantes oleosos. A una vacuna, y un kit de partes que comprende las partículas de replicón y el adyuvante oleoso. También a los métodos y usos para la elaboración y el uso de la vacuna y de los componentes del kit.
MX2020005584A 2017-12-04 2018-12-03 Vacunacion con particulas de replicon y adyuvante oleoso. MX2020005584A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762594342P 2017-12-04 2017-12-04
US201762607101P 2017-12-18 2017-12-18
PCT/EP2018/083297 WO2019110481A1 (en) 2017-12-04 2018-12-03 Vaccination with replicon particles and oil adjuvant

Publications (1)

Publication Number Publication Date
MX2020005584A true MX2020005584A (es) 2020-09-14

Family

ID=64661329

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020005584A MX2020005584A (es) 2017-12-04 2018-12-03 Vacunacion con particulas de replicon y adyuvante oleoso.
MX2023012390A MX2023012390A (es) 2017-12-04 2020-07-13 Vacunacion con particulas de replicon y adyuvante oleoso.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023012390A MX2023012390A (es) 2017-12-04 2020-07-13 Vacunacion con particulas de replicon y adyuvante oleoso.

Country Status (9)

Country Link
US (1) US20200323975A1 (es)
EP (1) EP3720488A1 (es)
JP (2) JP7354106B2 (es)
KR (1) KR20200095479A (es)
CN (1) CN111447948A (es)
BR (1) BR112020011044A2 (es)
CA (1) CA3084042A1 (es)
MX (2) MX2020005584A (es)
WO (1) WO2019110481A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3082959A1 (en) * 2017-12-04 2019-06-13 Intervet International B.V. Canine lyme disease vaccine
JP2023539771A (ja) 2020-09-07 2023-09-19 インターベット インターナショナル ベー． フェー． Ｈａ抗体陽性ターゲットのためのｈａステムワクチン
AR124849A1 (es) 2021-02-11 2023-05-10 Intervet Int Bv Vacuna para mycoplasma bovis
EP4370150A1 (en) 2021-07-13 2024-05-22 Intervet International B.V. Overcoming antibody-interference in avians
CN118139640A (zh) 2021-10-25 2024-06-04 英特维特国际股份有限公司 保护仔猪抵抗甲型猪流感病毒感染的疫苗

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0382271T3 (da) 1989-02-04 1995-05-01 Akzo Nobel Nv Tocoler som adjuvanser i vacciner
JPH11269093A (ja) * 1998-01-22 1999-10-05 Shionogi & Co Ltd 油性アジュバントワクチン製剤
BR0206312A (pt) 2001-01-04 2004-02-17 Univ Saskatchewan Composição de vacina, uso sobrenadante de cultura celular de escherichia coli enteroemorrágica (ehec), e, métodos para a geração de uma resposta imunológica em um mamìfero contra um antìgeno de escherichia coli enteroemorrágica (ehec) secretado, e 0157:h7 enteroemorrágica (ehec 0157:h7) secretado, e para a redução da colonização de escherichia coli enteroemorrágica (ehec) em um ruminante
EP1651666B1 (en) 2003-07-11 2009-05-27 Alphavax, Inc. Alphavirus-based cytomegalovirus vaccines
ATE420965T1 (de) 2004-05-18 2009-01-15 Alphavax Inc Von tc-83 abgeleitete alphavirus-vektoren, partikel und verfahren
US7805252B2 (en) 2005-08-16 2010-09-28 Dna Twopointo, Inc. Systems and methods for designing and ordering polynucleotides
CN101802199B (zh) 2007-06-21 2012-08-22 阿尔法瓦克斯公司 用于α病毒结构蛋白表达的无启动子盒
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US7561973B1 (en) 2008-07-31 2009-07-14 Dna Twopointo, Inc. Methods for determining properties that affect an expression property value of polynucleotides in an expression system
US8126653B2 (en) 2008-07-31 2012-02-28 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
US7561972B1 (en) 2008-06-06 2009-07-14 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
MX2011002071A (es) * 2008-08-29 2011-04-05 Boehringer Ingelheim Vetmed Vacuna para el virus del nilo occidental.
CN102307477B (zh) * 2009-01-05 2015-07-29 埃皮托吉尼西斯股份有限公司 佐剂组合物及使用方法
CA2766907A1 (en) 2009-07-06 2011-01-13 Novartis Ag Self replicating rna molecules and uses thereof
JP6025721B2 (ja) 2010-07-06 2016-11-16 ノバルティス アーゲー カチオン性水中油型エマルジョン
EP2471926A3 (en) * 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
BR122019023542B1 (pt) * 2011-03-14 2022-02-15 Boehringer Ingelheim Vetmedica, Inc Composição imunogênica compreendendo uma ou mais cepas de vírus da rinite equina b (erbv) inativado e seu método de preparação
JP5872685B2 (ja) 2011-05-26 2016-03-01 インターベット インターナショナル ベー． フェー． 免疫刺激性オリゴデオキシヌクレオチド
RU2587633C2 (ru) 2011-05-26 2016-06-20 Интервет Интернэшнл Б.В. Иммуностимулирующие олигодезоксинуклеотиды
RU2606846C2 (ru) 2011-07-06 2017-01-10 Новартис Аг Эмульсии типа "масло в воде", которые содержат нуклеиновые кислоты
MX362166B (es) * 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
CN104853770A (zh) * 2012-07-06 2015-08-19 诺华股份有限公司 免疫原性组合物及其应用
RU2018137034A (ru) 2016-03-23 2020-04-23 Интервет Интернэшнл Б.В. Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
EP3558351B1 (en) 2016-12-23 2022-01-26 Intervet International B.V. Combination vaccine for swine

Also Published As

Publication number Publication date
MX2023012390A (es) 2023-11-01
BR112020011044A2 (pt) 2020-11-17
RU2020119613A (ru) 2022-01-12
JP7354106B2 (ja) 2023-10-02
JP2023145596A (ja) 2023-10-11
JP2021505558A (ja) 2021-02-18
KR20200095479A (ko) 2020-08-10
WO2019110481A1 (en) 2019-06-13
CN111447948A (zh) 2020-07-24
RU2020119613A3 (es) 2022-04-14
CA3084042A1 (en) 2019-06-13
US20200323975A1 (en) 2020-10-15
EP3720488A1 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
MX2023012390A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX2022006603A (es) Vacuna contra el virus de la influenza de amplio espectro.
MX2018012880A (es) Metodos para proporcionar arn de hebra sencilla.
MD4733C1 (ro) Anticorpi anti-TIGIT
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2017002803A (es) Coronavirus bovino atenuado y vacunas relacionadas.
MY191539A (en) Streptococcal vaccine
PH12017500627A1 (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
MX2017016896A (es) Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
MX2016010838A (es) Vacunas de proproteina convertasa subtilisina/kexina tipo 9 (pcsk9).
TN2014000518A1 (en) Reassortant btv and ahsv vaccines
HK1258252A1 (zh) 腺嘌呤綴合物化合物及其作為疫苗佐劑的用途
PH12017501795A1 (en) Pestivirus vaccines for congenital tremors
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
PH12018500201A1 (en) Enhanced immune response in porcine species
MX2017015279A (es) Exasomas y su uso como vacunas.
IL284249A (en) A preparation that includes a vaccine additive
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
EP3347044A4 (en) BIRD FLUID VACCINE COMBINATION WITH VIRUS-RELATED PARTICLES AND NOVEL AUXILIARY SUBSTANCES
PH12019501173A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
EA202090236A1 (ru) Иммуногенные композиции senecavirus a и способы с ними
MX2018003173A (es) Vacunas de salmonella choleraesuis-salmonella typhimurium.